Unnamed: 0,title,date,stock,sentiment
211828.0,"Cannabis Stock Gainers And Losers From May 20, 2020",2020-05-20 18:14:00-04:00,CARA,negative
211829.0,Cara Therapeutics shares are trading higher after Cantor Fitzgerald maintained its Overweight rating on the stock and raised its price target from $34 to $40 per share.,2020-05-19 08:58:00-04:00,CARA,positive
211830.0,"Cantor Fitzgerald Reiterates Overweight on Cara Therapeutics, Raises Price Target to $40",2020-05-19 07:27:00-04:00,CARA,negative
211831.0,"Cannabis Stock Gainers And Losers From May 14, 2020",2020-05-14 17:15:00-04:00,CARA,negative
211832.0,"Cannabis Stock Gainers And Losers From May 11, 2020",2020-05-11 17:02:00-04:00,CARA,negative
211833.0,"Cara Therapeutics Q1 EPS $(0.620), Inline, Sales $8.093M Beat $4.760M Estimate",2020-05-11 16:06:00-04:00,CARA,neutral
211834.0,"The Week Ahead In Biotech: Virtual Conference Presentations, Clovis PDUFA Date In The Spotlight",2020-05-10 15:40:00-04:00,CARA,neutral
211835.0,10 Biggest Price Target Changes For Wednesday,2020-04-22 08:08:00-04:00,CARA,neutral
211836.0,"Cantor Fitzgerald Reiterates Overweight on Cara Therapeutics, Raises Price Target to $34",2020-04-22 06:39:00-04:00,CARA,negative
211837.0,"Cannabis Stock Gainers And Losers From April 21, 2020",2020-04-21 21:04:00-04:00,CARA,negative
